1. Home
  2. JOF vs SENS Comparison

JOF vs SENS Comparison

Compare JOF & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JOF

Japan Smaller Capitalization Fund Inc

HOLD

Current Price

$11.83

Market Cap

334.3M

Sector

Finance

ML Signal

HOLD

Logo Senseonics Holdings Inc.

SENS

Senseonics Holdings Inc.

HOLD

Current Price

$6.84

Market Cap

301.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
JOF
SENS
Founded
1990
1996
Country
Japan
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Industrial Machinery/Components
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
334.3M
301.2M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
JOF
SENS
Price
$11.83
$6.84
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$18.38
AVG Volume (30 Days)
51.8K
1.0M
Earning Date
01-01-0001
05-08-2026
Dividend Yield
3.33%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$16,389,000.00
Revenue This Year
N/A
$74.15
Revenue Next Year
N/A
$58.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.85
52 Week Low
$9.45
$0.41
52 Week High
$12.76
$8.75

Technical Indicators

Market Signals
Indicator
JOF
SENS
Relative Strength Index (RSI) 60.82 63.71
Support Level $10.21 $5.40
Resistance Level $11.98 $7.45
Average True Range (ATR) 0.18 0.39
MACD 0.01 0.18
Stochastic Oscillator 86.55 93.25

Price Performance

Historical Comparison
JOF
SENS

About JOF Japan Smaller Capitalization Fund Inc

Japan Smaller Capitalization Fund Inc is a closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investments in smaller capitalization Japanese equity securities. Its portfolio of investments consists of different sectors such as banks, chemicals, construction, electric appliances, financing business, food, Information and Communication, Utilities, Real Estate, and others.

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.

Share on Social Networks: